drugset / Trial / NCT01259102
Examine Plasma Concentrations of Buprenorphine Following Reapplication of Buprenorphine Transdermal System (BTDS) After Variable Application Site Rest Periods
Non-randomizedParallel-groupOpen-label
Summary
The purpose of this study is to determine the pharmacokinetics of BTDS following same-site patch reapplication after rest intervals.
Timeline
- Start
- 2000-11
- Primary completion
- 2001-03
- Completion
- 2001-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Buprenorphine transdermal patch | Unknown | 10 ug | Other |
Indications
No indication recorded.